DK0532629T3 - 1-Piperidinyl-alkanoylarylsulfonamid-derivater - Google Patents

1-Piperidinyl-alkanoylarylsulfonamid-derivater

Info

Publication number
DK0532629T3
DK0532629T3 DK91911167.4T DK91911167T DK0532629T3 DK 0532629 T3 DK0532629 T3 DK 0532629T3 DK 91911167 T DK91911167 T DK 91911167T DK 0532629 T3 DK0532629 T3 DK 0532629T3
Authority
DK
Denmark
Prior art keywords
piperidinyl
alkanoylarylsulfonamid
derivatives
alkanoylarylsulfonamides
direct
Prior art date
Application number
DK91911167.4T
Other languages
Danish (da)
English (en)
Inventor
Albert A Carr
Richard C Dage
Thaddeus R Nieduzak
John E Koerner
Tung Li
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0532629T3 publication Critical patent/DK0532629T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Tires In General (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK91911167.4T 1990-06-07 1991-05-15 1-Piperidinyl-alkanoylarylsulfonamid-derivater DK0532629T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53478490A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
DK0532629T3 true DK0532629T3 (da) 1996-11-25

Family

ID=24131528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91911167.4T DK0532629T3 (da) 1990-06-07 1991-05-15 1-Piperidinyl-alkanoylarylsulfonamid-derivater

Country Status (14)

Country Link
EP (1) EP0532629B1 (ja)
JP (1) JP3032294B2 (ja)
KR (1) KR100200461B1 (ja)
AT (1) ATE144899T1 (ja)
AU (1) AU650031B2 (ja)
CA (1) CA2084082C (ja)
DE (1) DE69123052T2 (ja)
DK (1) DK0532629T3 (ja)
ES (1) ES2096651T3 (ja)
FI (1) FI98456C (ja)
GR (1) GR3022327T3 (ja)
HU (1) HU214587B (ja)
NO (1) NO179205C (ja)
WO (1) WO1991018603A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6954194A (en) * 1993-06-23 1995-01-17 Merrell Dow Pharmaceuticals Inc. Piperidin-1-yl-2,2-dialkylpropanonearylsulfonamide derivatives
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
TWI249526B (en) * 1998-03-13 2006-02-21 Aventis Pharma Inc Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
IL150650A0 (en) 2000-01-20 2003-02-12 Eisai Co Ltd Piperidine derivatives and pharmaceutical compositions containing the same
KR20050114641A (ko) 2003-03-07 2005-12-06 아스텔라스세이야쿠 가부시키가이샤 2,6-이치환된 스티릴을 갖는 질소 함유 헤테로환 유도체
JP5400843B2 (ja) * 2011-09-06 2014-01-29 本田技研工業株式会社 車両構造

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof
PH25458A (en) * 1987-08-24 1991-07-01 Eisai Co Ltd Piperidine derivatives, therapeutic, preventive agents
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5064838A (en) * 1988-01-21 1991-11-12 Merrell Dow Pharmaceuticals 1,4-disubstituted-piperidinyl compounds as pain relievers
NZ236501A (en) * 1989-12-21 1992-12-23 Merrell Dow Pharma Piperidine derivatives and antithrombotic compositions

Also Published As

Publication number Publication date
FI98456B (fi) 1997-03-14
GR3022327T3 (en) 1997-04-30
FI925518A0 (fi) 1992-12-04
DE69123052T2 (de) 1997-03-06
ES2096651T3 (es) 1997-03-16
WO1991018603A1 (en) 1991-12-12
EP0532629B1 (en) 1996-11-06
KR930700441A (ko) 1993-03-15
EP0532629A4 (ja) 1994-03-09
HUT64517A (en) 1994-01-28
HU9203856D0 (en) 1993-04-28
ATE144899T1 (de) 1996-11-15
JPH06501242A (ja) 1994-02-10
CA2084082A1 (en) 1991-12-08
FI98456C (fi) 1997-06-25
KR100200461B1 (ko) 1999-06-15
CA2084082C (en) 2002-03-19
AU7992291A (en) 1991-12-31
NO179205B (no) 1996-05-20
NO924694L (no) 1992-12-04
AU650031B2 (en) 1994-06-09
JP3032294B2 (ja) 2000-04-10
NO924694D0 (no) 1992-12-04
HU214587B (hu) 1998-04-28
DE69123052D1 (de) 1996-12-12
FI925518A (fi) 1992-12-04
NO179205C (no) 1996-08-28
EP0532629A1 (en) 1993-03-24

Similar Documents

Publication Publication Date Title
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
PT641343E (pt) Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase
DE59108923D1 (de) Photochemisches Stabilisieren von Wolle
SE9004060D0 (sv) Bensazepin- och bensotiazepin-derivat
DK0532629T3 (da) 1-Piperidinyl-alkanoylarylsulfonamid-derivater
ATE137225T1 (de) Dihydrochinolin nmda antagonisten
FI930411A0 (fi) Bombesin antagonister
DK0457324T3 (da) Heterocycliske NMDA antagonister
NO901273D0 (no) Mikrobiell nedbrytning av flerverdige halogenerte aromater
KR920021881U (ko) 최루분사용
LV10421A (lv) Jaunie tetrahidronaftalina atvasinajumi
LV5395A3 (lv) Panemiens tablesu iegusanai
KR950032052U (ko) 탁자 다리 부착구의 구조
KR940026816U (ko) 비누의 편리한 사용구
ITMI921866A1 (it) Uso dell'oxatomide come agente antitosse
BR7302113U (pt) Estante-gaveteiro
SE9203080D0 (sv) Lindragare foer bruk under is